Cogstate Limited (CGS.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 0.8650 |
| Open | 0.8250 |
| Bid | 0.9000 x 0 |
| Ask | 0.9500 x 0 |
| Day's range | 0.8250 - 0.9400 |
| 52-week range | 0.7950 - 1.6200 |
| Volume | |
| Avg. volume | 255,014 |
| Market cap | 160.532M |
| Beta (5Y monthly) | 0.14 |
| PE ratio (TTM) | 18.80 |
| EPS (TTM) | 0.0500 |
| Earnings date | 21 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.82 |
Simply Wall St.Cogstate Full Year 2024 Earnings: EPS Beats Expectations
Cogstate ( ASX:CGS ) Full Year 2024 Results Key Financial Results Revenue: US$43.4m (up 7.4% from FY 2023). Net income...
Simply Wall St.Cogstate Limited's (ASX:CGS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
It is hard to get excited after looking at Cogstate's (ASX:CGS) recent performance, when its stock has declined 9.9...
PR NewswireTHREAD AND COGSTATE PARTNER TO SUPPORT CNS RESEARCH VIA NEXT GENERATION ECOA TECHNOLOGY AND LEADING COGNITIVE TESTING SOLUTIONS
Thread, a leading decentralized research and electronic clinical outcome assessment (eCOA) provider, today announced a collaboration with cognitive science leaders Cogstate Limited (ASX:CGS). The partnership combines Cogstate's best-in-class clinical and cognitive science solutions in digital assessment, endpoint data quality, remote assessments services, and deep experience in central nervous system (CNS) disorders with Thread's next-generation, proprietary no-code configurable eCOA platform in
© 2024 Yahoo. All rights reserved.